Rege Nephro Co., Ltd.
Company Name:Rege Nephro Co., Ltd.
Company Overview:
A clinical-stage biotech company utilizing induced pluripotent stem cell (iPSC)
Purpose of the exhibition:
As part of our global business expansion, we aim to establish a foundation in the Middle East through this exhibition, using it as a stepping stone for promoting our Doppler Lidar systems in the region
Company Website: https://www.regenephro.co.jp/en
Products
Small molecule for ADPKD
Cell therapy for CKD
Small molecule for ADPKD
Medicine for ADPKD which could be the first-in-class and first-line therapy
Cell therapy for CKD
Improving renal function by implanting iPSC-derived nephron progenitor cells into a damaged kidney
